TP53 and serous adenocarcinoma: Type II cancers include aggressive malignancies, such as high grade serous carcinomas, carcinosarcoma, and undifferentiated carcinomas with mutations most notable in tumor protein 53 (TP53) and breast cancer susceptibility gene (BRCA)[4].